Efficacy of antiviral therapy and host-virus interactions visualised using serial liver sampling with fine-needle aspirates
Novel therapies for chronic hepatitis B (CHB), such as RNA interference, target all viral RNAs for degradation, whereas nucleoside analogues are thought to block reverse transcription with minimal impact on viral transcripts. However, limitations in technology and sampling frequency have been obstac...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
September 2023
|
| In: |
JHEP reports
Year: 2023, Jahrgang: 5, Heft: 9, Pages: 1-10 |
| ISSN: | 2589-5559 |
| DOI: | 10.1016/j.jhepr.2023.100817 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jhepr.2023.100817 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S2589555923001489 |
| Verfasserangaben: | Samuel C. Kim, Jeffrey J. Wallin, Yanal Ghosheh, Muhammad Atif Zahoor, Juan Diego Sanchez Vasquez, Shirin Nkongolo, Scott Fung, Patricia Mendez, Jordan J. Feld, Harry L.A. Janssen, Adam J. Gehring |
| Zusammenfassung: | Novel therapies for chronic hepatitis B (CHB), such as RNA interference, target all viral RNAs for degradation, whereas nucleoside analogues are thought to block reverse transcription with minimal impact on viral transcripts. However, limitations in technology and sampling frequency have been obstacles to measuring actual changes in HBV transcription in the liver of patients starting therapy. |
|---|---|
| Beschreibung: | Online veröffentlicht am 19. Juni 2023, Artikelversion vom 4. August 2023 Gesehen am 07.12.2023 |
| Beschreibung: | Online Resource |
| ISSN: | 2589-5559 |
| DOI: | 10.1016/j.jhepr.2023.100817 |